On The Insider: Palin on SNL?
Find Articles in:
all
Business
Reference
Technology
News
Sports
Health
Autos
Arts
Home & Garden
advertisement
advertisement

Content provided in partnership with
Thomson / Gale

Pozen Inc

BT Catalyst,  Dec, 1999  

Pozen Inc. of Chapel Hill has acquired an exclusive worldwide license to a novel serotonin receptor antagonist discovered by F. Hoffmann-La Roche Ltd. of Basel, Switzerland. The compound is being developed as a migraine prophylactic agent.

COPYRIGHT 1999 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning